WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Inc Stock Ownership - Who owns Bridgebio Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bridgebio Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Neil KumarChief Executive Officer2025-04-2275,000$34.11
$2.56MSell
Andrea EllisDirector2025-04-1410,000$35.00
$350.00kSell
Andrea EllisDirector2025-04-1410,000$8.45
$84.50kBuy
Andrea EllisDirector2025-04-0130,000$8.45
$253.50kBuy
Andrea EllisDirector2025-04-0130,000$34.05
$1.02MSell
Neil KumarChief Executive Officer2025-03-2575,000$36.87
$2.76MSell
Hannah ValantineDirector2025-03-0612,875$16.75
$215.66kBuy
Hannah ValantineDirector2025-03-0612,875$32.58
$419.51kSell
Kkr Genetic Disorder LP10% Owner2025-03-056,000,000$32.96
$197.76MSell
Brian C. StephensonCFO and Treasurer2025-02-258,500$17.00
$144.50kBuy

1 of 5

BBIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BBIO insiders and whales buy or sell their stock.

BBIO Shareholders

What type of owners hold Bridgebio Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP19.43%36,900,661$1.34BInsider
Viking Global Performance LLC14.02%26,620,991$969.54MInsider
Kohlberg Kravis Roberts Co LP13.30%25,260,971$920.00MInstitution
Viking Global Investors LP13.23%25,120,991$914.91MInstitution
Viking Global Investors LP11.62%22,055,375$803.26MInsider
Kkr Genetic Disorder LP10.14%19,260,971$701.48MInsider
Vanguard Group Inc7.94%15,077,915$549.14MInstitution
Blackrock Inc7.22%13,709,646$499.31MInstitution
Neil Kumar4.25%8,072,223$293.99MInsider
State Street Corp3.26%6,182,627$225.17MInstitution

1 of 3

BBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BBIO60.03%39.97%Net SellingNet Selling
MDGL25.70%74.30%Net SellingNet Buying
TGTX55.24%44.76%Net Selling
JAZZ27.91%72.09%Net SellingNet Selling
RVMD90.68%9.32%Net BuyingNet Selling
View Top Biotech Stocks

Bridgebio Pharma Stock Ownership FAQ

Who owns Bridgebio Pharma?

Bridgebio Pharma (NASDAQ: BBIO) is owned by 93.05% institutional shareholders, 61.95% Bridgebio Pharma insiders, and 0.00% retail investors. Kkr Group Partnership LP is the largest individual Bridgebio Pharma shareholder, owning 36.90M shares representing 19.43% of the company. Kkr Group Partnership LP's Bridgebio Pharma shares are currently valued at $1.42B.

If you're new to stock investing, here's how to buy Bridgebio Pharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.